Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Avid Bioservices Inc

CDMO
Current price
12.28 USD -0.04 USD (-0.32%)
Last closed 12.29 USD
ISIN US05368M1062
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 787 935 424 USD
Yield for 12 month +164.66 %
1Y
3Y
5Y
10Y
15Y
CDMO
21.11.2021 - 28.11.2021

Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California. Address: 14191 Myford Road, Tustin, CA, United States, 92780

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

12.75 USD

P/E ratio

Dividend Yield

Current Year

+139 911 000 USD

Last Year

+149 266 000 USD

Current Quarter

+40 173 000 USD

Last Quarter

+42 975 000 USD

Current Year

+7 318 001 USD

Last Year

+31 480 000 USD

Current Quarter

+5 713 000 USD

Last Quarter

+5 500 000 USD

Key Figures CDMO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -7 687 000 USD
Operating Margin TTM -6.11 %
PE Ratio
Return On Assets TTM -3.05 %
PEG Ratio
Return On Equity TTM -115.84 %
Wall Street Target Price 12.75 USD
Revenue TTM 142 358 000 USD
Book Value 0.92 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 6.5 %
Dividend Yield
Gross Profit TTM 31 480 000 USD
Earnings per share -2.29 USD
Diluted Eps TTM -2.29 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY -79.7 %
Profit Margin -101.27 %

Dividend Analytics CDMO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CDMO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:7
Payout Ratio
Last Split Date 10.07.2017
Dividend Date 10.07.2017

Stock Valuation CDMO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 88.4956
Enterprise Value Revenue 6.7292
Price Sales TTM 5.5349
Enterprise Value EBITDA 107.8717
Price Book MRQ 13.3941

Financials CDMO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CDMO

For 52 weeks

4.07 USD 12.48 USD
50 Day MA 11.07 USD
Shares Short Prior Month 13 505 759
200 Day MA 9.08 USD
Short Ratio 3.79
Shares Short 11 717 635
Short Percent 18.53 %